PDCD1 and hepatocellular carcinoma: For instance, the celecoxib derivative 2,5‐dimethyl celecoxib inhibits PD‐1 expression and enhances IFN‐γ production in NK and T cells through the gut microbiota‐AMPK‐mTOR pathway, suppressing HCC growth in mouse models [82].